The benefits, limitations and opportunities of preclinical models for neonatal drug development

• Главные авторы: Sarah Campion (Автор), Amy Inselman (Автор), Belinda Hayes (Автор), Costanza Casiraghi (Автор), David Joseph (Автор), Fabrizio Facchinetti (Автор), Fabrizio Salomone (Автор), Georg Schmitt (Автор), Julia Hui (Автор), Karen Davis-Bruno (Автор), Karen Van Malderen (Автор), LaRonda Morford (Автор), Luc De Schaepdrijver (Автор), Lutz Wiesner (Автор), Stephanie Kourula (Автор), Suna Seo (Автор), Susan Laffan (Автор), Vijay Urmaliya (Автор), Connie Chen (Автор)
• Формат: ‌
• Опубликовано: The Company of Biologists, 2022-04-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Increased research to improve preclinical models to inform the development of therapeutics for neonatal diseases is an area of great need. This article reviews five common neonatal diseases - bronchopulmonary dysplasia, retinopathy of prematurity, necrotizing enterocolitis, perinatal hypoxic-ischemi...